Report on intrauterine drag exposure during second trimester of pregnancy in a heroin-associated death

Therapeutic Drug Monitoring

Volumn 21, Issue 6, 1999, Pages 593-597

  Pötsch, Lucia ^a   Skopp, Gisela ^b   Emmerich, Patricia ^a   Becker, Jürgen ^a   Ogbuhui, Sylvester ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Drug analysis; Intrauterine drug exposure Amniotic fluid; Maternal placental fetal unit; Prenatal heroin exposure

Indexed keywords

DIAMORPHINE; CODEINE; MORPHINE 6 GLUCURONIDE; MORPHINE DERIVATIVE; MORPHINE-6-GLUCURONIDE;

ADOLESCENT; AMNION FLUID; ARTICLE; CASE REPORT; DRUG DISPOSITION; FEMALE; FETOPLACENTAL UNIT; FETUS CIRCULATION; GESTATIONAL AGE; HEROIN DEPENDENCE; HUMAN; MATERNAL MORTALITY; PLACENTAL TRANSFER; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TOXICOLOGY; AUTOPSY; BODY FLUID; CHEMISTRY; FATALITY; FETOMATERNAL TRANSFUSION; FETUS; HAIR; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION; TISSUE DISTRIBUTION;

ADOLESCENT; AMNIOTIC FLUID; AUTOPSY; BODY FLUIDS; CODEINE; FATAL OUTCOME; FEMALE; FETUS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HAIR; HEROIN; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; MORPHINE DERIVATIVES; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; TISSUE DISTRIBUTION;

EID: 0032585695     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199912000-00002     Document Type: Article

References (30)

1. Behnke M, Eyler DF. The consequences of prenatal substance use for the developing fetus, newborn and young child. Int J Addict 1993;28:1341-91
2. Gilogley KM, Evans AT, Hansen RL, et al. The perinatal impact of cocaine, amphetamine and opiate use detected by universal intrapartum screening. Am J Obstet Gynecot 1990;163:1535-42
3. Bourget P, Roulot C, Fernandez H. Models for placental transfer studies on drugs. Clin Pharmacokinet 1995;28:161-80
4. Lee CC, Chiang CN. Maternal fetal transfer of abused substances: pharmacokinetic and pharmacodynamic data. In: Chiang CN, Lee CC, eds. Prenatal drug exposure: kinetics and dynamics. Rockville, MD. NIDA Res Monogr 1985;60:110-47
5. Schneider H, Sodha RJ, Progler M, Young M. Permeability of the human placenta for hydrophilic substances studied in the isolated dually perfused in vitro perfused lobe. Contrib Gynecol Obstet 1985;13:98-103
6. Ching MS, Czuba MA, Mihaly GW. Mechanism of triamterene transfer across the human placenta. J Pharmacol Exp Ther 1988; 246:1093-7
7. Mihalay WG, Morgan DJ. Placental drug transfer: Effects of gestational age and species. Pharmacol Ther 1984;23:253-66
8. Morgan DJ. Drug disposition in mother and fetus. Clin Exp Pharmacol Physiol 1997;24:869-73
9. Bost R, Kemp P, Hnilica V. Tissue distribution of methamphetamine and amphetamine in premature infants. J Anal Toxicol 1989; 13:300-2
10. Kwong TC, Ryan RM. Detection of intrauterine illicit drug exposure by newborn drug testing. Clin Chem 1997;43:235-42
11. Stewart JL, Meeker JE. Fetal and infant death associated with maternal methamphetamine abuse. J Anal Toxicol 1997;21:515-7
12. Sturner WQ, Sweeney KG, Callery RT, Haley NR. Cocaine babies: the scourge of the 90s. J Forensic Sci 1991;36:34-9
13. Röhrich J, Zörntlein S, Pötsch L, et al. Effect of the shampoo Ultra Clean on drug concentrations in human hair. Int J Legal Med 1999 (submitted)
14. Baselt R, Cravey R, eds. Disposition of toxic drugs and chemicals in man. Chicago: Year Book Medical Publishers; 1989
15. Bogusz MJ, Maier RD, Driessen S. Morphine, morphine-3-glucuronide, morphine-6-glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry - liquid chromatography in body fluids of heroin victims. J Anal Toxicol 1997;21:346-55
16. Iwersen S, Schmoldt A, Schulz F, Püschel K. Evidence of gestational heroin exposure by comparative analysis of fetal and maternal body fluids, tissues and hair in a heroin-related death. J Anal Toxicol 1998;22:296-8
17. Gerdin E, Rane A, Lindberg B. Transplacental transfer of morphine in man. J Perinat Med 1990;18:305-12
18. Pacifici GM, Säwe J, Kager L, Rane A. Morphine glucuronidation in human, fetal and adult liver. Eur J Clin Pharmacol 1982;22: 553-8
19. Polin RA, Fox WW, eds. Fetal and neonatal physiology. Philadelphia: Saunders; 1992
20. Carrupt P, Testa A, Bechalany A, et al. Morphine-6-glucuronide and morphine-3-glucuronide as molecular chameleons with unexpected lipophilicity. J Med Chem 1991;43:1272-5
21. Hakkola J, Pasenen M, Purkunen R, et al. Expression of xenobiotic metabolizing cytochrom P450 forms in adult and fetal liver. Biochem Pharmacol 1994;48:59-64
22. Juchau MR. Drug biotransformation in the placenta. Pharmacol Ther 1980;8:501-24
23. Rama Sastry BV. Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions, and placental function. Reprod Fertil Dev 1991;3:355-72
24. Shimada T, Yamazaki H, Mimura M, et al. Characterization of microsomal cytochromal P450 enzymes involved in the oxidation of xenobiotic chemicals in fetal livers and lungs. Drug Metab Dipos 1996;24:515-22
25. Aderjan R, Hofmann S, Schmitt G, Skopp G. Morphine and morphine glucuronides in serum of heroin consumers and in heroin related deaths determined by HPLC with native fluorescence detection. J Anal Toxicol 1995;19:163-8
26. Ripple MG, Goldberger BA, Caplan YH, et al. Detection of cocaine and metabolites in human amniotic fluid. J Anal Toxicol 1992;16:328-31
27. Hook JB, Bailie MD. Perinatal renal pharmacology. Annu Rev Pharmacol Toxicol 1979;19:491-09
28. Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995;28:235-69
29. Sandler M, ed. Amniotic fluid and in clinical significance. New York: Marcel Dekker; 1981
30. Sandberg JA, Olsen GD. Cocaine and metabolite concentrations in fetal guinea pig after chronic maternal cocaine administration. J Pharmacol Exper Therap 1992;260:587-91.